Timothy Shafer, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 1154 Vt Route 30, Townshend, VT 05353 Phone: 802-365-4354 |
Moss Linder, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 185 Grafton Road, Townshend, VT 05353 Phone: 802-365-4331 |
Dr. Jesper Jerome Brickley, DO Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 185 Grafton Road, Townshend, VT 05353 Phone: 802-365-7357 |
Alexandra Barstow, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 185 Grafton Rd, Townshend, VT 05353 Phone: 802-365-4331 Fax: 802-365-7031 |
Dr. Ewa Arnold, M.D Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 185 Grafton Road, Townshend, VT 05353 Phone: 802-365-4331 |
George P. Terwilliger, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 185 Grafton Rd, Townshend, VT 05353 Phone: 802-365-3725 Fax: 603-354-6605 |
Kimona Alin, M.D. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 185 Grafton Rd., Townshend, VT 05353 Phone: 802-365-4331 |
Robert Backus, M.D. Family Medicine - Geriatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 185 Grafton Rd., Townshend, VT 05353 Phone: 802-365-4331 |
Edward Thomas Mulhern, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 152 Grafton Road, Townshend, VT 05353 Phone: 802-365-4318 Fax: 802-365-4285 |
Lynn Elise Madsen, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 152 Grafton Road, Townshend, VT 05353 Phone: 802-365-4318 Fax: 802-365-4285 |
News Archive
As the pandemic persists, COVID-19 has claimed more than 200,000 lives in the United States and damaged the public health system and economy.
The Iowa plan had been held up by funding concerns. In other news on mental health issues, North Carolina is also weighing major changes in its system.
Idenix Pharmaceuticals, Inc., a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral diseases, today announced that it has initiated a 3-day proof-of-concept study of IDX320, a protease inhibitor for the treatment of hepatitis C virus (HCV) infection, under a Clinical Trial Application (CTA). The study is evaluating IDX320 in treatment-naive hepatitis C genotype 1-infected patients.
Eating an apple a day might in fact help keep the cardiologist away, new research suggests.
› Verified 3 days ago